In silico evaluation of atazanavir as a potential HIV main protease inhibitor and its comparison with new designed analogs | ||
| dc.conicet.organizacion | Graduate University of Advanced Technology | |
| dc.conicet.organizacion | Graduate University of Advanced Technology | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Física del Sur. Universidad Nacional del Sur. Departamento de Física. Instituto de Física del Sur | |
| dc.contributor.author | Yoosefian, Mehdi | |
| dc.contributor.author | Moghani, Maryam Zeraati | |
| dc.contributor.author | Juan, Alfredo | |
| dc.date.issued | 2022-06 | |
| dc.description.abstract | Starting three decades ago and spreading rapidly around the world, acquired immunodeficiency syndrome (AIDS) is an infectious disease distinct from other contagious diseases by its unique ways of transmission. Over the past few decades, research into new drug compounds has been accompanied by extensive advances, and the design and manufacture of drugs that inhibit virus enzymes is one way to combat the AIDS virus. Since blocking enzyme activity can kill a pathogen or correct a metabolic imbalance, the design and use of enzyme inhibitors is a new approach against viruses. We carried out an in-depth analysis of the efficacy of atazanavir and its newly designed analogs as human immunodeficiency virus (HIV) protease inhibitors using molecular docking. The best designed analogs were then compared with atazanavir by the molecular dynamics simulation. The most prom ising results were ultimately found based on the docking analysis for HIV protease. Several exhibited an esti mated free binding energy lower than − 9.45 kcal/mol, indicating better prediction results than the atazanavir. ATV7 inhibitor with antiviral action may be more beneficial for infected patients with HIV. Molecular dynamics analysis and binding energy also showed that the ATV7 drug had more inhibitory ability than the atazanavir drug. | es |
| dc.description.fil | Fil: Yoosefian, Mehdi. Graduate University of Advanced Technology; Irán | |
| dc.description.fil | Fil: Moghani, Maryam Zeraati. Graduate University of Advanced Technology; Irán | |
| dc.description.fil | Fil: Juan, Alfredo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Física del Sur. Universidad Nacional del Sur. Departamento de Física. Instituto de Física del Sur; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Yoosefian, Mehdi; Moghani, Maryam Zeraati; Juan, Alfredo; In silico evaluation of atazanavir as a potential HIV main protease inhibitor and its comparison with new designed analogs; Elsevier; Computers In Biology And Medicine; 145; 105523; 6-2022; 1-7 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0010-4825 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/203741 | |
| dc.journal.ciudad | Amsterdam | es |
| dc.journal.number | 105523 | es |
| dc.journal.pagination | 1-7 | es |
| dc.journal.pais | Países Bajos | es |
| dc.journal.title | Computers In Biology And Medicine | es |
| dc.journal.volume | 145 | es |
| dc.language.iso | eng | es |
| dc.publisher | Elsevier | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0010482522003158 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1016/j.compbiomed.2022.105523 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ | * |
| dc.subject | ATAZANAVIR | es |
| dc.subject | HIV PROTEASE | es |
| dc.subject | MOLECULAR DYNAMICS | es |
| dc.subject | PROTEASE INHIBITOR | es |
| dc.subject.classification | Otras Ciencias Físicas | es |
| dc.subject.classification | Ciencias Físicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | In silico evaluation of atazanavir as a potential HIV main protease inhibitor and its comparison with new designed analogs | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.ae87ca97-12b7-44af-93f7-7f0b71e38436_B.pdf
- Tamaño:
- 4.34 MB
- Formato:
- Adobe Portable Document Format